Differential evaluation of the quality of life of women with chronic pelvic pain syndrome depending on concomitant pathologies.

O.B. Solomko, S.О. Shurpyak
In: Reproductive health of woman · 2022 · pp. 41–44 · doi:10.30841/2708-8731.8.2022.273295 · W4322759290
article OA: diamond CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-07 ⓘ

This study assessed quality of life in 150 women with chronic pelvic pain syndrome, finding significantly lower scores in both endometriosis and benign proliferative disease groups compared to controls, with greater impairment in the latter.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 ⓘ

The paper studied how quality of life differs among women with chronic pelvic pain syndrome (CХТБ) depending on suspected concomitant gynecologic pathologies, using a cohort of 150 patients divided into group A (CХТБ with suspected endometriosis) and group B (CХТБ with suspected combined benign proliferative reproductive organ diseases), compared with 50 healthy controls. Quality of life was assessed with the SF-36 questionnaire across eight domains, revealing reduced quality of life in all SF-36 scales for the CХТБ groups versus controls, with statistically significant differences (p<0.001), and additional significant intergroup differences across all SF-36 scales between group A and group B (p<0.05), most notably in role limitations due to physical health and social functioning. A key limitation explicitly reflected in the design is that concomitant diagnoses appear based on clinical suspicion rather than confirmed pathology. This paper is centrally about endometriosis — it compares SF-36 quality-of-life outcomes in chronic pelvic pain syndrome patients with suspected endometriosis versus other benign proliferative gynecologic conditions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The World Health Organization defines quality of life as a person’s perception of his position in life in the context of the culture and value systems in which he lives, as well as in relation to his goals, expectations, standards and problems. Today, chronic pelvic pain is considered a condition that can significantly affect the quality of life. At the same time, there are significant prospects for using this method to evaluate the effectiveness of treatment. The objective: to evaluate of changes in the quality of life of patients with chronic pelvic pain syndrome (CPPS) depending on accompanying pathologies. Materials and methods. The examined cohort included 150 patients with CPPS, who according to the clinical manifestations were divided into groups A and B: group A (n=74) – patients with CPPS and suspicion for endometriosis and group B (n=76) – patients with CPPS and suspicion for combined benign proliferative diseases of reproductive organs. The control group included healthy women (n=50).SF-36 questionnaire which involves the use of eight scales of questions to determine the level of quality of life was used to assess the quality of life.Results. A decrease in quality of life was found in all the scales of the SF-36 questionnaire in patients with CPPS. A statistically significant difference was found in all scales between A and B groups compared to the control group (p<0.001).In addition, a significant difference was found in all scales of the questionnaire between the group with CPPS and combined benign proliferative diseases of the reproductive organs compared to the group with CPPS and endometriosis (p<0.05). At the same time, the most significant changes were found in the scale of physical role functioning and the scale of social role functioning.Conclusions. The decrease in indicators on all scales of the SF-36 questionnaire in patients of the studied cohort confirms that CPPS significantly affects all areas of their quality of life. Significantly lower indicators were observed in the group with CPPS and combined hyperproliferative pathology compared to the group with CPPS and endometriosis (p<0.05).

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK